(Q43039760)

English

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

scientific article published in November 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

liver cirrhosis

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Patrick Maisonneuve

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

object named as

Mario U Mondelli

6

0 references

author name string

Andrea Crosignani

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sonia Rossi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Enrico Silini

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1350-1356

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

21 January 2018

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21826

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.21826

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039760&oldid=1978311424"